FY2024 Earnings Forecast for RARE Issued By Wedbush
Wedbush upped their FY2024 EPS estimates for Ultragenyx Pharmaceutical in a report released on Thursday, January 23rd. Wedbush analyst L. Chico now forecasts that the biopharmaceutical company will ...
FY2024 Earnings Estimate for RARE Issued By Leerink Partnrs
Stock analysts at Leerink Partnrs lifted their FY2024 EPS estimates for Ultragenyx Pharmaceutical in a report released on ...
Ascendis Pharma Provides Business and Strategic Roadmap Update at 43rd Annual J.P. Morgan Healthcare Conference
Ascendis positioned to drive rapid revenue growthCOPENHAGEN, Denmark, Jan. 12, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) ...
News Medical19d
An Overview of X-Linked Disorders and X Chromosome Aneuploidies
4 Hypophosphatemia occurs when there are genetic ... 5 Mohr-Tranebjaerg Syndrome (MTS) is a rare X-linked neurodegenerative disorder that causes early-onset hearing loss, gradual and progressive ...
SciELO4d
New treatments for rare bone diseases: hypophosphatemic rickets/osteomalacia
This article will revise the novel treatment of two conditions that lead to hypophosphatemia with high FGF-23 levels: tumor-induced osteomalacia (TIO) and X-linked hypophosphatemic rickets (XLH). The ...
Frontiers23d
Case report: Prolonged and severe hungry bone syndrome after parathyroidectomy in X-linked hypophosphatemia
This condition can be a complication of X-linked hypophosphatemia (XLH), a rare genetic disease characterized by renal phosphate loss and consequent hypophosphatemia. Parathyroidectomy is considered ...
pharmaphorum8d
AI technology: A game-changer for rare disease diagnosis
Last year, five possible cases of X-Linked Hypophosphatemia (XLH) were identified via MendelScan technology and all of these cases were moved forward by clinical reviewers. This is a highly ...